LT4034122T - Hiperfenilalaninemijos gydymo būdai - Google Patents

Hiperfenilalaninemijos gydymo būdai

Info

Publication number
LT4034122T
LT4034122T LTEPPCT/US2020/052871T LTUS2020052871T LT4034122T LT 4034122 T LT4034122 T LT 4034122T LT US2020052871 T LTUS2020052871 T LT US2020052871T LT 4034122 T LT4034122 T LT 4034122T
Authority
LT
Lithuania
Prior art keywords
hyperphenylalanemia
treatment methods
treatment
methods
Prior art date
Application number
LTEPPCT/US2020/052871T
Other languages
English (en)
Inventor
Niel SMITH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=72827023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4034122(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of LT4034122T publication Critical patent/LT4034122T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/US2020/052871T 2019-09-25 2020-09-25 Hiperfenilalaninemijos gydymo būdai LT4034122T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962905720P 2019-09-25 2019-09-25
PCT/US2020/052871 WO2021062264A1 (en) 2019-09-25 2020-09-25 Methods for treating hyperphenylalaninemia

Publications (1)

Publication Number Publication Date
LT4034122T true LT4034122T (lt) 2025-11-10

Family

ID=72827023

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2020/052871T LT4034122T (lt) 2019-09-25 2020-09-25 Hiperfenilalaninemijos gydymo būdai

Country Status (23)

Country Link
US (1) US20220362249A1 (lt)
EP (1) EP4034122B1 (lt)
JP (2) JP7661315B2 (lt)
KR (1) KR20220070477A (lt)
CN (1) CN114650825A (lt)
AU (1) AU2020353676B2 (lt)
BR (1) BR112022003719A2 (lt)
CA (1) CA3150003A1 (lt)
DK (1) DK4034122T3 (lt)
ES (1) ES3041002T3 (lt)
FI (1) FI4034122T3 (lt)
HR (1) HRP20251268T1 (lt)
HU (1) HUE073483T2 (lt)
IL (1) IL291565B1 (lt)
JO (1) JOP20220042A1 (lt)
LT (1) LT4034122T (lt)
MX (1) MX2022003585A (lt)
PL (1) PL4034122T3 (lt)
PT (1) PT4034122T (lt)
RS (1) RS67295B1 (lt)
SI (1) SI4034122T1 (lt)
SM (1) SMT202500493T1 (lt)
WO (1) WO2021062264A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CA3102105A1 (en) 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリンの薬学的に許容される塩
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui
US12691119B2 (en) 2021-02-09 2026-07-28 Ptc Therapeutics Mp, Inc. Methods for treating covid-19 with sepiapterin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US6036949A (en) 1998-03-05 2000-03-14 Amarillo Biosciences, Inc. Treatment of fibromyalgia with low doses of interferon
ES2586945T3 (es) * 2014-03-31 2016-10-19 Vasopharm Gmbh Composiciones farmacéuticas sólidas que comprenden derivados de biopterina y usos de dichas composiciones
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) * 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) * 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリンの薬学的に許容される塩

Also Published As

Publication number Publication date
MX2022003585A (es) 2022-04-19
ES3041002T3 (en) 2025-11-06
JP2022549834A (ja) 2022-11-29
JOP20220042A1 (ar) 2023-01-30
BR112022003719A2 (pt) 2022-05-31
DK4034122T3 (da) 2025-09-15
EP4034122A1 (en) 2022-08-03
FI4034122T3 (fi) 2025-10-08
RS67295B1 (sr) 2025-11-28
HRP20251268T1 (hr) 2025-12-05
PT4034122T (pt) 2025-09-18
WO2021062264A1 (en) 2021-04-01
SMT202500493T1 (it) 2026-01-12
HUE073483T2 (hu) 2026-01-28
AU2020353676B2 (en) 2026-04-30
JP2025111476A (ja) 2025-07-30
IL291565B1 (en) 2026-04-01
SI4034122T1 (sl) 2025-12-31
KR20220070477A (ko) 2022-05-31
US20220362249A1 (en) 2022-11-17
CN114650825A (zh) 2022-06-21
EP4034122B1 (en) 2025-08-13
CA3150003A1 (en) 2021-04-01
PL4034122T3 (pl) 2026-01-26
IL291565A (en) 2022-05-01
AU2020353676A1 (en) 2022-04-14
JP7661315B2 (ja) 2025-04-14

Similar Documents

Publication Publication Date Title
IL282794A (en) Therapeutic methods
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
IL290670A (en) Sterilisation method
IL269371A (en) Treatment methods
EP3757187A4 (en) SURFACE TREATMENT AGENT
IL269174A (en) Methods for treating complement-mediated diseases and disorders
IL282311A (en) Use of reboxetine to treat narcolepsy
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
EP3953503C0 (en) ELECTROLYTIC POLISHING PROCESS
IL281736A (en) Methods of treating myeloproliferative disorders
IL292502A (en) Therapeutic methods using vadadustat
DK3294769T3 (da) Behandling for multipelt myelom (mm)
IL281600A (en) Methods of treating cancer
IL286040A (en) Methods of treating al amyloidosis
IL281845A (en) Combination therapy for the treatment of cancer
IL308399A (en) Methods of treating cancer
EP3597225A4 (en) TREATMENT PROCESS
PT3952858T (pt) Método de tratamento de tumores
IL282041A (en) Egfr inhibitors for treating keratodermas
IL281343A (en) Methods for treating pancreatitis
EP3493821A4 (en) METHOD OF TREATING THE RESPIRATORY TRACT
IL270867A (en) Treatment method
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
IL286857A (en) Methods for the treatment of beta-thalassemia